secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silo Pharma, Inc. (SILO)
CIK:        0001514183
Form:       8-K
Filed at:   2026-08-17T20:05:47+00:00
Accession:  0001213900-26-090748
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Silo Pharma shareholders approve 37.5x increase in authorized shares to 250M
----------------------------------------------------------------------------

- Shareholders approved increase in authorized common stock from 6,666,667 to 250,000,000 shares on Aug 14, 2026.
- Vote: 498,224 for, 190,599 against, 8,485 abstain; no broker non-votes.
- Directors re-elected: Eric Weisblum, Wayne Linsley, Kevin Munoz, Jeff Pavell; each received ~359k for votes.
- Ratified Salberg & Company as independent auditor for FY2026; 690,743 for, 2,571 against.
- Adjournment proposal approved 556,797 for, 131,873 against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1514183/000121390026090748/0001213900-26-090748-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1514183/000121390026090748/ea0302240-8k_silo.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-090748

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer